Responses in patients receiving sequential paclitaxel post progression on PD1 inhibitors

Publication date: Available online 28 March 2018
Source:Oral Oncology
Author(s): Ammar Sukari, Misako Nagasaka, Nadine Abdallah
This report describes highlights the dramatic responses seen in patients who were given paclitaxel post progression on immunotherapy. There are multiple mechanisms by which synergistic effects of immunotherapy and chemotherapy occur. Further prospective studies on chemotherapy and immunotherapy are eagerly awaited.



https://ift.tt/2pNqvfY